537 New COVID-19 Cases Since Thursday at Noon
& 4 New Deaths Reported
35,814 Total Positive Cases & 1,029 Total Deaths
MOHAVE COUNTY, AZ (January 3, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 537 new confirmed COVID-19 cases reported since Thursday at noon. There are also 4 new deaths reported. ALL are previously reported cases.
Of the 4 deaths, one is a 70-79 person from the Lake Havasu service area.
One death is an 80-89 person from the Kingman service area.
Two deaths are from the Bullhead City service area. One is an 80-89 person and one is 90+.
ALL 537 new confirmed positive cases remain under investigation.
Of the 537 new confirmed cases, there are 253 confirmed cases in the Bullhead City service area. There are 113 new confirmed cases in the Kingman service area. There are 163 new confirmed cases in the Lake Havasu City service area. There are 0 new confirmed cases in the North County service area. There are 8 new confirmed cases in an Undetermined or Unknown area of the county.
Of the 253 new confirmed cases in the Bullhead City area, eleven are 0-10; seventeen are 11-19; forty one are 20-29; thirty five are 30-39; thirty are 40-49; thirty six are 50-59; forty six are 60-69; twenty five are 70-79; eleven are 80-89; one is 90+.
Of the 113 new confirmed cases in the Kingman area, eight are 0-10; three are 11-19; twenty one are 20-29; twenty are 30-39; fifteen are 40-49; fifteen are 50-59; eighteen are 60-69; nine are 70-79; three are 80-89; one is 90+.
Of the 163 new confirmed cases in the Lake Havasu City area, one is 0-10; thirteen are 11-19; thirty are 20-29; nineteen are 30-39; thirteen are 40-49; twenty five are 50-59; thirty four are 60-69; seventeen are 70-79; eight are 80-89; three are 90+.
Of the 8 new confirmed cases in an Unknown/Undermined area of the county, one is 0-10; one is 11-19; one is 30-39; one is 40-49; three are 60-69; one is 90+.
TOTAL POSITIVE CASES SINCE 1ST CASE REPORTED –—–35,814
TOTAL RECOVERED THUS FAR: 29,307
AVERAGE AGE OF CASES SINCE CASE #1: 45.4
AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 72.2
The Omicrom variant has been identified in several Arizona counties; however, the MCDPH has not been notified of any Omicrom cases in Mohave County. Meanwhile, CDC scientists are working with partners to gather data and virus samples that can be studied to answer important questions about the Omicron variant as the variant spreads in the U.S. and other parts of the world. Scientific experiments have already started. CDC will provide updates as soon as possible.
In the United States, CDC uses genomic surveillance to track variants of SARS-CoV-2, the virus that causes COVID-19 to more quickly identify and act upon these findings to best protect the public’s health. CDC established multiple ways to connect and share genomic sequence data being produced by CDC, public health laboratories, and commercial diagnostic laboratories within publicly accessible databases maintained by the National Center for Biotechnology Informationexternal icon (NCBI) and the Global Initiative on Sharing Avian Influenza Dataexternal icon (GISAID).
CDC reports that if a variant is circulating at 0.1% frequency, there is a 99% chance that it will be detected in CDC’s national genomic surveillance. CDC has been using genomic surveillance throughout the course of the pandemic to track variants of SARS-CoV-2, the virus that causes COVID-19, and inform public health practice.
The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus and how easily Omicron spreads compared to Delta remains unknown. CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms.
More data are needed to know if Omicron infections, and especially reinfections and breakthrough infections in people who are fully vaccinated, cause more severe illness or death than infection with other variants.
The CDC says Vaccines remain the best public health measure to protect people from COVID-19, slow transmission, and reduce the likelihood of new variants emerging.
MCDPH has been notified of a scam in which citizens receive a call from a person claiming to be employees of the Mohave County Department of Public Health and offering home visits to administer COVID-19 vaccine. The MCDPH does not and will not directly contact residents to offer home-based COVID-19 vaccination appointments.*
IMPORTANT NOTE: As a good reminder, the MCDPH(Mohave County Department of Public Health) only reports confirmed COVID-19 cases and deaths, unlike the ADHS, which reports “probables” as well. Therefore, the county’s numbers and those from the state are not the same.
Even those fully vaccinated can still get COVID-19. The vaccine reduces the severity of the virus and hospitalizations. It does not mean individuals are totally immune from Covid-19.
Updated Current Vaccination Information
The U.S. Food and Drug Administration (FDA) has authorized, and the Centers for Disease Control and Prevention (CDC) has recommended booster doses of all three COVID-19 vaccines available in the United States.
For the latest updated information on booster doses and eligibility, please visit:
Monoclonal Antibody Therapy (FDA Emergency Use Authorization)
While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.
Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like the virus that causes COVID-19. That’s why mAb treatment may help patients who are at high risk for severe symptoms or hospitalization.
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.
General eligibility information is below.
- Individuals who have tested positive for COVID-19 and are within ten days of onset
- Unvaccinated individuals who have had close contact with a COVID positive person
- Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
Each facility has its own standards for administering the Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.
Kingman Regional Medical Center (KRMC)
Phone Number: 928-681-8699
Western Arizona Regional Medical Center (WARMC)
Phone number: 928-763- 2273
Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)
Phone number: 928-505-1030
Veklury® (Remdesivir) (FDA approved)
Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body.
Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.
Protect yourself and others
o Get the COVID-19 vaccine (ages 12 and up).
o Wash your hands often with soap and water for at least 20 seconds. If soap and water are not available, use an alcohol-based hand sanitizer.
o Avoid touching your eyes, nose, and mouth with unwashed hands.
o Stay home as much as possible, but especially when you are sick.
o Put distance between yourself and other people, at least 6 feet.
o Avoid gathering in groups of 10 or more.
o Cover your cough or sneeze with a tissue, then throw the tissue in the trash.
o Clean and disinfect frequently touched objects and surfaces.
o Wear a face covering when in indoor public places.
COVID-19 questions?, please call 928-753-8665